Common Contracts

Contract

Amendment Agreement • February 16th, 2021

• Contract Type
  Amendment Agreement
• Filed
  February 16th, 2021

THIS AMENDMENT AGREEMENT 2 is made effective as of the date of last signature (the “Effective Date”). TENTO SMLUVNÍ DODATEK Č. 2 nabývá účinnosti k datu posledního podpisu („Datum účinnosti“). “BETWEEN”: (1) Biogen Idec Research Limited located at: Innovation House, 70 Norden Road, Maidenhead, Berkshire, SL6 4AY, United Kingdom (“Biogen”); (2) Nemocnicí Jihlava, příspěvková organizace, located at Vrchlického 4630/59, 586 33 Jihlava, Czech Republic, Identification Number: 00090 638, Tax Identification Number: CZ000 90 638, represented by MUDr. Lukáš Velev, MHA, Director (the "Institution"); (3) , located at U , Czech Republic (the "Investigator"); and (4) IQVIA RDS Czech Republic, s.r.o. with offices located at Pernerova 691/42, 186 00 Praha 8 – Karlín, Czech Republic, Identification Number: 247 68 651, Tax Identification Number: CZ247 68 651, acting on the basis of Power of Attorney dated July 6, 2017. (“CRO”) (together the "Parties" or individually a "Party"). „MEZI“: (1) Biogen Idec